| JXSB2101001 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.1) | Supplementary Application | 2021-04-01 | | Genentech Inc;F Hoffmann-La Roche Ltd(Switzerland) | | | view |
| JXSL2101067 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-07-20 | | F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd | | | view |
| JYSB2000352 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2020-07-30 | | Roche Diagnostics GmbH;Roche Registration GmbH | Filed | 2020-08-17 | view |
| JXSB2400102 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-07-25 | | Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland) | | | view |
| JYSB2500118 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2025-05-21 | | Roche Registration GmbH | | | view |
| JXSS2101014 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Import Drug Application | 2021-06-30 | | Roche Diagnostics GmbH;Roche (China) Holding Ltd;Roche Registration GmbH | | | view |
| JYSB2101105 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2021-08-13 | | Roche Diagnostics GmbH;Roche Registration GmbH | | | view |
| JXSL2000160 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(3.1) | Import Drug Application | 2020-09-24 | | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2020-09-23 | view |
| JYSB2400218 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2024-09-28 | | Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland);Roche Registration GmbH | | | view |
| JXSS1900004 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Import Drug Application | 2019-02-25 | | Roche Diagnostics GmbH;Roche Registration GmbH | Certificate Issued | 2020-02-13 | view |
| JYSZ2400037 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | License Renew | 2024-07-04 | | Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland);Roche (China) Holding Ltd;Roche Registration GmbH | | | view |
| JYSB2500091 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2025-04-03 | | Roche Registration GmbH | | | view |
| JXSB2101066 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-10-14 | | Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland) | | | view |
| JXSB2200011 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2022-01-25 | | Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland) | | | view |
| JYSB2400168 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2024-07-30 | | Roche Registration GmbH | | | view |
| JYSB2000674 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products | Supplementary Application | 2020-12-28 | | Roche Diagnostics GmbH;Roche Registration GmbH | Certificate Issued | 2021-03-02 | view |
| JXSB2101002 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.1) | Supplementary Application | 2021-04-01 | | Genentech Inc;F Hoffmann-La Roche Ltd(Switzerland) | | | view |
| JXSB2400169 | 阿替利珠单抗注射液（皮下注射） | atezolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2024-12-14 | | Roche Diagnostics GmbH;Roche Pharma (Schweiz) AG | | | view |
| JXSL2100021 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(3.1) | Import Drug Application | 2021-02-11 | | F Hoffmann-La Roche Ltd(Switzerland) | In Review | 2021-02-11 | view |
| JXSB2101092 | 阿替利珠单抗注射液 | atezolizumab | Injection | Biological Products(2.2) | Supplementary Application | 2021-11-23 | | Roche Diagnostics GmbH;F Hoffmann-La Roche Ltd(Switzerland) | | | view |
